Literature DB >> 27426631

A Cross-National Examination of Differences in Classification of Lifetime Alcohol Use Disorder Between DSM-IV and DSM-5: Findings from the World Mental Health Survey.

Tim Slade1, Wai-Tat Chiu2, Meyer Glantz3, Ronald C Kessler2, Luise Lago1, Nancy Sampson2, Ali Al-Hamzawi4, Silvia Florescu5, Jacek Moskalewicz6, Sam Murphy7, Fernando Navarro-Mateu8, Yolanda Torres de Galvis9, Maria Carmen Viana10, Miguel Xavier11, Louisa Degenhardt1.   

Abstract

BACKGROUND: The current study sought to examine the diagnostic overlap in DSM-IV and DSM-5 alcohol use disorder (AUD) and determine the clinical correlates of changing diagnostic status across the 2 classification systems.
METHODS: DSM-IV and DSM-5 definitions of AUD were compared using cross-national community survey data in 9 low-, middle-, and high-income countries. Participants were 31,367 respondents to surveys in the World Health Organization's World Mental Health Survey Initiative. The Composite International Diagnostic Interview, version 3.0, was used to derive DSM-IV and DSM-5 lifetime diagnoses of AUD. Clinical characteristics, also assessed in the surveys, included lifetime DSM-IV anxiety; mood and drug use disorders; lifetime suicidal ideation, plan, and attempt; general functional impairment; and psychological distress.
RESULTS: Compared with DSM-IV AUD (12.3%, SE = 0.3%), the DSM-5 definition yielded slightly lower prevalence estimates (10.8%, SE = 0.2%). Almost one-third (n = 802) of all DSM-IV abuse cases switched to subthreshold according to DSM-5 and one-quarter (n = 467) of all DSM-IV diagnostic orphans switched to mild AUD according to DSM-5. New cases of DSM-5 AUD were largely similar to those who maintained their AUD across both classifications. Similarly, new DSM-5 noncases were similar to those who were subthreshold across both classifications. The exception to this was with regard to the prevalence of any lifetime drug use disorder.
CONCLUSIONS: In this large cross-national community sample, the prevalence of DSM-5 lifetime AUD was only slightly lower than the prevalence of DSM-IV lifetime AUD. Nonetheless, there was considerable diagnostic switching, with a large number of people inconsistently identified across the 2 DSM classifications.
Copyright © 2016 by the Research Society on Alcoholism.

Entities:  

Keywords:  Alcohol Use Disorder; DSM-5; DSM-IV; Prevalence

Mesh:

Year:  2016        PMID: 27426631      PMCID: PMC5129606          DOI: 10.1111/acer.13134

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  27 in total

1.  A prospective study of the factors influencing entry to alcohol and drug treatment.

Authors:  Constance Weisner; Helen Matzger
Journal:  J Behav Health Serv Res       Date:  2002-05       Impact factor: 1.505

2.  Who goes to alcohol and drug treatment? Understanding utilization within the context of insurance.

Authors:  Constance Weisner; Helen Matzger; Tammy Tam; Laura Schmidt
Journal:  J Stud Alcohol       Date:  2002-11

3.  Comparison of DSM-5 Classifications of Alcohol Use Disorders With Those of DSM-IV, DSM-III-R, and ICD-10 in a General Population Sample in Sweden.

Authors:  Andreas Lundin; Mats Hallgren; Mikael Forsman; Yvonne Forsell
Journal:  J Stud Alcohol Drugs       Date:  2015-09       Impact factor: 2.582

4.  Commentary on Laslett et al. (2011): alcohol-related collateral damage and the broader issue of alcohol's social costs.

Authors:  Thomas F Babor
Journal:  Addiction       Date:  2011-09       Impact factor: 6.526

5.  DSM-5 SUD diagnoses: changes, reactions, remaining open questions.

Authors:  Deborah Hasin
Journal:  Drug Alcohol Depend       Date:  2015-03-01       Impact factor: 4.492

6.  Alcohol abuse in developed and developing countries in the World Mental Health Surveys: Socially defined consequences or psychiatric disorder?

Authors:  Meyer D Glantz; Maria Elena Medina-Mora; Maria Petukhova; Laura Helena Andrade; James C Anthony; Giovanni de Girolamo; Ron de Graaf; Louisa Degenhardt; Koen Demyttenaere; Silvia Florescu; Oye Gureje; Josep Maria Haro; Itsuko Horiguchi; Elie G Karam; Stanislav Kostyuchenko; Sing Lee; Jean-Pierre Lépine; Herbert Matschinger; Yehuda Neumark; Jose Posada-Villa; Rajesh Sagar; Dan J Stein; Toma Tomov; J Elisabeth Wells; Somnath Chatterji; Ronald C Kessler
Journal:  Am J Addict       Date:  2013-08-29

7.  Concordance between DSM-5 and DSM-IV nicotine, alcohol, and cannabis use disorder diagnoses among pediatric patients.

Authors:  Sharon M Kelly; Jan Gryczynski; Shannon Gwin Mitchell; Arethusa Kirk; Kevin E O'Grady; Robert P Schwartz
Journal:  Drug Alcohol Depend       Date:  2014-04-13       Impact factor: 4.492

8.  Delay to first treatment contact for alcohol use disorder.

Authors:  Cath Chapman; Tim Slade; Caroline Hunt; Maree Teesson
Journal:  Drug Alcohol Depend       Date:  2014-12-10       Impact factor: 4.492

9.  Patterns of DSM-IV alcohol abuse and dependence criteria among adolescents and adults: results from the 2001 National Household Survey on Drug Abuse.

Authors:  Thomas C Harford; Bridget F Grant; Hsiao-Ye Yi; Chiung M Chen
Journal:  Alcohol Clin Exp Res       Date:  2005-05       Impact factor: 3.455

10.  Diagnostic orphans: comparing self-report lifetime course to groups with DSM-IV alcohol abuse and dependence.

Authors:  Orla McBride; Gary Adamson; Brendan Bunting; Siobhan McCann
Journal:  Addict Behav       Date:  2008-08-03       Impact factor: 3.913

View more
  10 in total

1.  Concordance between the diagnostic guidelines for alcohol and cannabis use disorders in the draft ICD-11 and other classification systems: analysis of data from the WHO's World Mental Health Surveys.

Authors:  Louisa Degenhardt; Chrianna Bharat; Raimondo Bruno; Meyer D Glantz; Nancy A Sampson; Luise Lago; Sergio Aguilar-Gaxiola; Jordi Alonso; Laura Helena Andrade; Brendan Bunting; Jose Miguel Caldas-de-Almeida; Alfredo H Cia; Oye Gureje; Elie G Karam; Mohammad Khalaf; John J McGrath; Jacek Moskalewicz; Sing Lee; Zeina Mneimneh; Fernando Navarro-Mateu; Carmen C Sasu; Kate Scott; Yolanda Torres; Vladimir Poznyak; Somnath Chatterji; Ronald C Kessler
Journal:  Addiction       Date:  2018-12-09       Impact factor: 6.526

Review 2.  CRF modulation of central monoaminergic function: Implications for sex differences in alcohol drinking and anxiety.

Authors:  Kristen E Pleil; Mary Jane Skelly
Journal:  Alcohol       Date:  2018-02-02       Impact factor: 2.405

3.  DSM-5 Alcohol Use Disorder Severity in Puerto Rico: Prevalence, Criteria Profile, and Correlates.

Authors:  Raul Caetano; Paul Gruenewald; Patrice A C Vaeth; Glorisa Canino
Journal:  Alcohol Clin Exp Res       Date:  2018-01-02       Impact factor: 3.455

4.  The associations between psychotic experiences and substance use and substance use disorders: findings from the World Health Organization World Mental Health surveys.

Authors:  Louisa Degenhardt; Sukanta Saha; Carmen C W Lim; Sergio Aguilar-Gaxiola; Ali Al-Hamzawi; Jordi Alonso; Laura H Andrade; Evelyn J Bromet; Ronny Bruffaerts; José Miguel Caldas-de-Almeida; Giovanni de Girolamo; Silvia Florescu; Oye Gureje; Josep M Haro; Elie G Karam; Georges Karam; Viviane Kovess-Masfety; Sing Lee; Jean-Pierre Lepine; Victor Makanjuola; Maria E Medina-Mora; Zeina Mneimneh; Fernando Navarro-Mateu; Marina Piazza; José Posada-Villa; Nancy A Sampson; Kate M Scott; Juan Carlos Stagnaro; Margreet Ten Have; Kenneth S Kendler; Ronald C Kessler; John J McGrath
Journal:  Addiction       Date:  2018-02-21       Impact factor: 6.526

5.  The epidemiology of drug use disorders cross-nationally: Findings from the WHO's World Mental Health Surveys.

Authors:  Louisa Degenhardt; Chrianna Bharat; Meyer D Glantz; Nancy A Sampson; Kate Scott; Carmen C W Lim; Sergio Aguilar-Gaxiola; Ali Al-Hamzawi; Jordi Alonso; Laura H Andrade; Evelyn J Bromet; Ronny Bruffaerts; Brendan Bunting; Giovanni de Girolamo; Oye Gureje; Josep Maria Haro; Meredith G Harris; Yanling He; Peter de Jonge; Elie G Karam; Georges E Karam; Andrzej Kiejna; Sing Lee; Jean-Pierre Lepine; Daphna Levinson; Victor Makanjuola; Maria Elena Medina-Mora; Zeina Mneimneh; Fernando Navarro-Mateu; José Posada-Villa; Dan J Stein; Hisateru Tachimori; Yolanda Torres; Zahari Zarkov; Somnath Chatterji; Ronald C Kessler
Journal:  Int J Drug Policy       Date:  2019-06-28

Review 6.  Role of corticotropin-releasing factor in alcohol and nicotine addiction.

Authors:  Sierra Simpson; Kokila Shankar; Adam Kimbrough; Olivier George
Journal:  Brain Res       Date:  2020-04-21       Impact factor: 3.252

7.  Cross-country and historical variation in alcohol consumption among older men and women: Leveraging recently harmonized survey data in 21 countries.

Authors:  Esteban Calvo; José T Medina; Katherine A Ornstein; Ursula M Staudinger; Linda P Fried; Katherine M Keyes
Journal:  Drug Alcohol Depend       Date:  2020-08-04       Impact factor: 4.492

8.  Comparison of DSM-IV and DSM-5 criteria for alcohol use disorders in VA primary care patients with frequent heavy drinking enrolled in a trial.

Authors:  Traci Takahashi; Gwen Lapham; Laura J Chavez; Amy K Lee; Emily C Williams; Julie E Richards; Diane Greenberg; Anna Rubinsky; Douglas Berger; Eric J Hawkins; Joseph O Merrill; Katharine A Bradley
Journal:  Addict Sci Clin Pract       Date:  2017-07-18

9.  A comparison of DSM-5 and DSM-IV agoraphobia in the World Mental Health Surveys.

Authors:  Annelieke M Roest; Ymkje Anna de Vries; Carmen C W Lim; Hans-Ulrich Wittchen; Dan J Stein; Tomasz Adamowski; Ali Al-Hamzawi; Evelyn J Bromet; Maria Carmen Viana; Giovanni de Girolamo; Koen Demyttenaere; Silvia Florescu; Oye Gureje; Josep Maria Haro; Chiyi Hu; Elie G Karam; José Miguel Caldas-de-Almeida; Norito Kawakami; Jean Pierre Lépine; Daphna Levinson; Maria E Medina-Mora; Fernando Navarro-Mateu; Siobhan O'Neill; Marina Piazza; José A Posada-Villa; Tim Slade; Yolanda Torres; Ronald C Kessler; Kate M Scott; Peter de Jonge
Journal:  Depress Anxiety       Date:  2019-02-06       Impact factor: 6.505

10.  Mental Health in Australia: Psychological Distress Reported in Six Consecutive Cross-Sectional National Surveys From 2001 to 2018.

Authors:  Joanne Enticott; Shrinkhala Dawadi; Frances Shawyer; Brett Inder; Ellie Fossey; Helena Teede; Sebastian Rosenberg; Ingrid Ozols Am; Graham Meadows
Journal:  Front Psychiatry       Date:  2022-04-01       Impact factor: 5.435

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.